Pipelinepharma

🌟 Pipelinepharma is excited to announce the launch of our Annual Subscription plan, providing access to the largest database of finished dosage formulations! The subscription includes:

🔹 Direct negotiation and collaboration with manufacturers, eliminating the need for any mediation.
🔹 No consultancy or brokerage commission fees.
🔹 Dedicated account manager for personalised support.

For the first 100 clients, the Subscription service is available at the cost of 125 euros per month, billed annually. That's a price lower than that of a single business trip. 🌍✈️💰

We are eager to cooperate with you in finding qualified products for your product pipeline. 🙌💊

▶️ Watch this video to learn more about the benefits of our Annual Subscription plan.



Link to video: https://bit.ly/3N45aKa

Subscription Plan for Pharmaceutical Buyers The Subscription plan is a paid service that provides exclusive benefits for pharma buyers looking for multiple products on the Pipelinepharma platform.

Are you looking to expand your business and increase pharma product sales in new markets? Then you need to check out the Pipelinepharma marketplace.

Our B2B platform offers a unique opportunity for manufacturers and suppliers to showcase their pharmaceuticals, medical devices and nutraceuticals to the extensive network of potential buyers.

And the best part is that you can list all your products for free for an unlimited time.

Take advantage of this opportunity to benefit from greater visibility and exposure. Find new partnerships in new markets and grow your business.

We invite you to sign up for Pipelinepharma's marketplace today to reach more customers and get quality leads:
https://bit.ly/3KvztbO

Attention B2B buyers, looking for new pharma products for your portfolio 💊🧪 Pipelinepharma has just made it easier for you to know if the products available in our marketplace fit your needs. The product cards are now enriched with valuable data to help you make informed sourcing decisions.

What's new? In addition to basic CTD and GMP information, product form, country of origin, and manufacturer, you can now get data about the product:

🔸 Shelf life
🔸 Stability zones
🔸 Minimum order quantity (MOQ)
🔸 Available deal types (licencing with supply, distribution, etc.)
🔸 Whether a CPP is available
🔸 Available packs and batch sizes
🔸 Countries where a product has been registered.product

All of this information is available free of charge to our registered visitors and can be easily accessed by logging into our platform.

Check it out here: https://bit.ly/3jTOXvb

Let's make 2023 a year of good deals! Find more matches, markets, and opportunities. Keep raising the bar together! ✨

With B2B conferences having a comeback in 2022, both pharma buyers and sellers have more opportunities to meet in person, re-kindle old ties and learn from one another. But are in-person events the best venue for finding new deal partners?

According to Pipelinepharma CEO Mindaugas Zagorskis, more and more pharma players are using a mix of offline and online channels to discover new business opportunities:

“Talking with Pharma representatives, both online and during live events, it seems that our traditionally conservative industry is becoming more and more open to new ideas. And in the changing business landscapes, solutions that can work in the background, generating leads and potential sales, can make a massive difference.”

Read more about how trade shows and B2B marketplaces complement each other in this latest article by our CEO:
https://bit.ly/3B5l8x4

Pharmaceutical products for sale | Pipelinepharma Pharma trade shows and B2B digital market places

What developments will shape the biopharmaceutical industry during the next several years? has shared their predictions, which are worth a closer look.👀

Here’s what is coming up:

📉 A cliff – the biggest in recent history – is likely to shave $26 billion off the pharma sales forecast for 2028. AbbVie’s $20 billion-a-year Humira will be first to lose protection next year, with mega-blockbusters including Keytruda, Opdivo, and Eliquis to follow.

💡 Oncology will likely generate the most sales in 2028 – more than double the next largest therapy area, CNS. Its forecast growth rate of nearly 12% is also among the highest.

🍔 The fight for the share of the growing market will increase as a new generation of more effective drugs arrives and payers loosen reimbursement strings. Evaluate puts combined obesity sales in 2028 above $11 billion.

🪴The importance of -based products for the industry will continue to grow, boosted by their high price levels and multiple patents.

👉 Find the full Evaluate Pharma World Preview 2022, Outlook to 2028: Patents and Pricing report here:
https://bit.ly/3TtznSV

Are you looking for new reliable deal partners? Pharma manufacturers can reach 10.000+ qualified pharma buyers worldwide and leverage high-potential B2B partnerships.

List all your products free of charge for unlimited time on the Pipelinepharma marketplace:
✅ Nutraceuticals
✅ Generics
✅ Biosimilars
✅ Medical devices

Find out more on Pipelinepharma: https://bit.ly/3gQyAh0

🏭 We have added pharma descriptions to many product cards in the Pipelinepharma marketplace. That way we seek to help buyers get a clearer picture of the manufacturer’s experience and competencies.

This adds another layer of information to the already detailed product descriptions. We hope this makes it easier for buyers to find suitable products from reputable manufacturers.

⚖️ Unlike other marketplaces, we do not disclose the manufacturer’s name. We want both sides to have equal leverage when choosing deal partners.

At the same time, we provide manufacturers with the opportunity to list all their products for free by adding detailed information about each product.

Helpful search filters ensure that products are easily discoverable by interested buyers.

At , we aim to provide equal value to buyers and sellers. Only by following this principle will we be able to help both parties to conclude mutually beneficial deals.

➡️ Check the Pipelinepfarma marketplace to search for new products to enrich your portfolio:

https://bit.ly/3T0eq2A

Being the largest B2B pharma marketplace for finished dosage products, Pipelinepharma has collected in-depth knowledge of numerous markets worldwide.🌍

So we want to share the latest industry insights with companies seeking a competitive edge — pharma buyers and suppliers.

Whether you’re preparing your go-to-market strategy or expanding your offering in a specific country, the Pipelinepharma research team is here to help.

Get an on-demand report on 70+ markets, including Germany, Denmark or Israel, that features the latest , and .

📍Got interested? Select a country, define a product, make an order and get the report in just 3 days to your inbox. Get a hold of the data that can make a huge difference today.

Want to get more information about our new Market research service? Find it here:

https://bit.ly/3qnWUIR